322.40
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt WST?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$324.13
Offen:
$321.43
24-Stunden-Volumen:
365.91K
Relative Volume:
0.78
Marktkapitalisierung:
$23.39B
Einnahmen:
$2.88B
Nettoeinkommen (Verlust:
$499.60M
KGV:
47.83
EPS:
6.74
Netto-Cashflow:
$321.60M
1W Leistung:
-2.61%
1M Leistung:
-2.81%
6M Leistung:
+12.00%
1J Leistung:
-21.30%
West Pharmaceutical Services Inc Stock (WST) Company Profile
Firmenname
West Pharmaceutical Services Inc
Sektor
Telefon
(610) 594-2900
Adresse
530 HERMAN O. WEST DRIVE, EXTON, PA
Vergleichen Sie WST mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
WST
West Pharmaceutical Services Inc
|
322.40 | 23.39B | 2.88B | 499.60M | 321.60M | 6.74 |
![]()
ISRG
Intuitive Surgical Inc
|
591.65 | 211.02B | 8.35B | 2.32B | 1.30B | 6.41 |
![]()
BDX
Becton Dickinson Co
|
229.52 | 65.90B | 20.64B | 1.73B | 2.94B | 6.02 |
![]()
ALC
Alcon Inc
|
89.81 | 44.42B | 9.76B | 1.16B | 665.00M | 2.34 |
![]()
RMD
Resmed Inc
|
237.43 | 34.88B | 4.93B | 1.25B | 1.38B | 8.47 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-01-08 | Eingeleitet | Citigroup | Buy |
2024-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
2024-12-12 | Hochstufung | UBS | Neutral → Buy |
2024-02-07 | Hochstufung | Jefferies | Hold → Buy |
2023-06-16 | Hochstufung | BofA Securities | Neutral → Buy |
2023-04-11 | Hochstufung | Stephens | Equal-Weight → Overweight |
2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
2022-11-30 | Eingeleitet | UBS | Neutral |
2022-10-28 | Herabstufung | BofA Securities | Buy → Neutral |
2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
2020-10-14 | Eingeleitet | Stephens | Equal-Weight |
2020-07-21 | Hochstufung | BofA Securities | Neutral → Buy |
2020-04-24 | Hochstufung | BofA/Merrill | Underperform → Neutral |
2019-12-12 | Herabstufung | BofA/Merrill | Neutral → Underperform |
2019-07-26 | Hochstufung | BofA/Merrill | Underperform → Neutral |
2019-05-01 | Herabstufung | Jefferies | Buy → Hold |
2019-04-23 | Eingeleitet | William Blair | Outperform |
2018-04-25 | Herabstufung | BofA/Merrill | Neutral → Underperform |
2018-01-24 | Eingeleitet | Goldman | Neutral |
2017-10-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
2017-10-03 | Eingeleitet | Stephens | Equal-Weight |
2017-09-15 | Hochstufung | Jefferies | Hold → Buy |
2016-10-28 | Hochstufung | Wells Fargo | Market Perform → Outperform |
2016-09-21 | Herabstufung | Wells Fargo | Outperform → Market Perform |
2016-03-22 | Eingeleitet | Wells Fargo | Outperform |
2010-05-14 | Bestätigt | UBS | Neutral |
2010-02-23 | Eingeleitet | Jefferies & Co | Buy |
2008-12-19 | Eingeleitet | UBS | Neutral |
Alle ansehen
West Pharmaceutical Services Inc Aktie (WST) Neueste Nachrichten
Will Segmental Performance Drive West Pharmaceutical's Q4 Earnings? - MSN
Injectable Drug Device Maker West Pharma Secures Ban At ITC - Law360
West Pharmaceutical Services Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Ex-Dividend Reminder: West Pharmaceutical Services, SouthState and Pinnacle Financial Partners - Nasdaq
Pharmaceutical Packaging Market Top Companies StudyOwens - openPR
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Pharmaceutical Glass Packaging Market: Current Analysis and Forecast (2023-2030) - UnivDatos Market Insights
Trust Point Inc. Buys 2,427 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Brokerages Set West Pharmaceutical Services, Inc. (NYSE:WST) PT at $430.20 - Defense World
West Pharmaceutical Services, Inc. (NYSE:WST) Receives $430.20 Average PT from Brokerages - MarketBeat
StockNews.com Upgrades West Pharmaceutical Services (NYSE:WST) to "Buy" - MarketBeat
Swedbank AB Boosts Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Pacer Advisors Inc. Has $1.89 Million Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Conestoga Capital Advisors LLC Buys 25,110 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Services Declares Q1 2025 Dividend - MSN
On-Body Drug Delivery Devices Market reached US$ 40.54 billion - openPR
West Pharmaceutical Services to Announce Q4 and Full-Year 2024 Results - MSN
West Pharmaceutical Services, Inc. (NYSE:WST) to Issue Quarterly Dividend of $0.21 - MarketBeat
Armstrong World Industries to Announce Q4 and Full-Year 2024 Financial Results - MyChesCo
Tokio Marine Asset Management Co. Ltd. Raises Stake in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Fulton Breakefield Broenniman LLC Takes Position in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Services (NYSE:WST) Raised to “Buy” at StockNews.com - Defense World
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
West to Host Fourth-Quarter and Full-Year 2024 Conference Call -January 30, 2025 at 06:01 am EST - Marketscreener.com
West to Host Fourth-Quarter and Full-Year 2024 Conference Call - Quantisnow
Enviri Corporation to Release Q4 and Full Year 2024 Results - MyChesCo
West Pharmaceutical Services Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
West Introduces Daikyo PLASCAP RUV closures in new nested format at Pharmapack - European Pharmaceutical Manufacturer
West Pharmaceutical sets first-quarter dividend at $0.21/share By Investing.com - Investing.com Canada
West Pharmaceutical sets first-quarter dividend at $0.21/share - MSN
West Pharmaceutical Services Maintains Quarterly Dividend at $0.21 Per Share; Payable Feb. 11 to Shareholders of Record on Feb. 7 - Marketscreener.com
West Announces First-Quarter Dividend - Finansavisen
West Pharmaceutical Services (NYSE:WST) shareholders have earned a 17% CAGR over the last five years - Simply Wall St
Indo-Asian News Service-WEST ANNOUNCES FIRST-QUARTER DIVIDEND - IANS India Pvt Ltd
Vial Closure From: West Pharmaceutical Services, Inc - Healthcare Packaging
Janney Montgomery Scott LLC Makes New $14.76 Million Investment in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Atomi Financial Group Inc. Raises Position in West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World
West Pharmaceutical Unveils New Nested Format for Daikyo PLASCAP RUV Closures - MSN
Universal Health Services, Inc. Schedules Q4 and Full-Year 2024 Results Announcement - MyChesCo
What You Need to Know Ahead of West Pharmaceutical Services’ Earnings Release - MSN
Beacon Investment Advisory Services Inc. Sells 2,138 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Services Inc. stock underperforms Thursday when compared to competitors - MarketWatch
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Riverbridge Partners LLC - MarketBeat
West launches Daikyo PLASCAP RUV closures in new nested format - Packaging Gateway
West Pharmaceutical Services, Inc. Introduces Daikyo PLASCAP RUV Closures in New Nested Format At Pharmapack - Marketscreener.com
Finanzdaten der West Pharmaceutical Services Inc-Aktie (WST)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):